Published in Clinical Oncology Week, June 30th, 2003
"Parathyroid hormone-related peptide (PTHrP) participates in the development of humoral hypercalcemia of malignancy. The peptide is thought to affect growth and differentiation of normal and neoplastic cells. The present study aimed at evaluation of the relationship between survival time and development of distant metastases in patients with ductal mammary carcinoma on the one hand and PTHrP expression on the other," scientists writing in the journal Virchows Archiv report.
"Immunocytochemical reactions using mouse monoclonal...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.